Home Investment Portfolio ArcticDx Innovation Type: Diagnostics Cancer Type: Other Funding Stage: Exit Fund: Compass Rose Development of a colon cancer risk prediction diagnostic tool Related news There are currently no news items related to this portfolio company. [contact-form-7 id="0b0c7a8" title="General Contact"]
